Gain Therapeutics Announces 2024 R&D Update on Parkinson's Disease with KOL & Analyst Insight -February 14, 2024 at 12:30 pm EST

Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 -- Gain Therapeutics, Inc., , a...

Related Keywords

Germany ,Israel ,Tel Aviv ,Hartaj Singh ,Joanne Taylor ,Eka Gigauri ,Roy Alcalay ,Matthias Alder ,Elio Ambrosio ,Nic Johnson ,Tiago Fleming Outeiro ,Oppenheimer Co ,Columbia University ,Company Annual Report On Form ,Movement Disorder Society ,Gain Therapeutics Inc ,Department Of Experimental Neurodegeneration ,Linkedin ,Nasdaq ,Silverstein Foundation For Parkinson ,Michaelj Fox Foundation For Parkinson Research ,Professor At Newcastle University ,University Medical Center ,Exchange Commission On ,Exchange Commission ,Research Development ,Key Opinion ,Symptomatic Treatment ,Gain Therapeutics Rd Update ,Senior Vice President ,Movement Disorders Division ,Tel Aviv Sourasky Medical Center ,Foundation Funded Parkinson ,Progression Markers Initiative ,Experimental Neurodegeneration ,Task Force ,Biological Definition ,Internation Parkinson ,Movement Disorder ,Silverstein Foundation ,Gain Therapeutics ,Site Directed Enzyme Enhancement Therapy ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,